CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 45 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2019. The put-call ratio across all filers is - and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $20,661,000 | +57.2% | 611,273 | +8.8% | 0.00% | +50.0% |
| Q1 2021 | $13,141,000 | -8.4% | 561,845 | +12.8% | 0.00% | 0.0% |
| Q4 2020 | $14,348,000 | +55.0% | 498,208 | +9.0% | 0.00% | 0.0% |
| Q3 2020 | $9,258,000 | -20.8% | 457,004 | +17.5% | 0.00% | -33.3% |
| Q2 2020 | $11,688,000 | +30.1% | 388,968 | +36.1% | 0.00% | +50.0% |
| Q1 2020 | $8,982,000 | -57.9% | 285,789 | -36.9% | 0.00% | 0.0% |
| Q4 2019 | $21,322,000 | +2950.4% | 452,654 | +317.9% | 0.00% | – |
| Q3 2019 | $699,000 | -45.9% | 108,318 | +2.9% | 0.00% | – |
| Q2 2019 | $1,292,000 | +6.5% | 105,234 | +17.5% | 0.00% | – |
| Q1 2019 | $1,213,000 | +1002.7% | 89,587 | +226.1% | 0.00% | – |
| Q4 2018 | $110,000 | +39.2% | 27,470 | +133.8% | 0.00% | – |
| Q3 2018 | $79,000 | – | 11,748 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP, LLC | 3,034,083 | $41,112,000 | 40.71% |
| Svennilson Peter | 4,677,939 | $63,386,000 | 33.76% |
| VHCP Management II, LLC | 726,677 | $9,846,000 | 2.88% |
| Casdin Capital, LLC | 1,556,999 | $21,097,000 | 2.32% |
| Cormorant Asset Management, LP | 1,271,687 | $17,231,000 | 1.16% |
| VHCP Management III, LLC | 66,667 | $903,000 | 0.53% |
| Hillhouse Capital Management | 317,921 | $4,308,000 | 0.18% |
| Orbimed Advisors | 835,842 | $11,326,000 | 0.18% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 66,186 | $897,000 | 0.13% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 253,400 | $3,434,000 | 0.13% |